More than ever, we remain by your side. COVID-19: PathoQuest services continuity update The COVID-19 pandemic has continued to rapidly evolve; many countries are facing the challenges of very high global risk levels. During health emergencies like this pandemic, one...
Press Release PathoQuest obtains Pharmaceutical Establishment status from French ANSM for its biological drug testing activities Pour la version en français de ce communiqué de presse : cliquez ici Paris, France – September 29, 2020 – PathoQuest, a leader in quality...
Press Release PathoQuest’s Paris Based Facility Obtains GLP Conformity Certificate for its Biologics Genomic Testing Services Based on Next-Generation Sequencing Technology Pour la version en français de ce communiqué de presse : cliquez ici PARIS, FRANCE, January 23,...
Press Release PathoQuest Secures 8 Million Euros in New Financing Paris, FRANCE — (BUSINESS WIRE) — September 5, 2019 — PathoQuest, a genomic expert company dedicated to the microbiology testing market and a leader in clinical diagnostics and biologics testing...
Press Release PathoQuest Names Dr. Christiane Honisch to Board of Directors PARIS, FRANCE – September 25, 2018 — PathoQuest, a genomic expert dedicated to the microbiology testing market, the leader in clinical diagnostics and biologics testing applications, today...
Press Release PathoQuest announces enrollment of first patient in IDENTIFY, a prospective clinical study assessing the medico-economic benefit of iDTECT™ Blood for the diagnosis of bloodstream infection in immunocompromised patients PARIS, FRANCE, May 22, 2018 –...